RxDoctor Payments Data

Alexis Franklin, PA

Physician Assistant · Dearborn Heights, MINPI 1134830045

Payments from drug & device makers

$518in general payments, 2019–2025

Across 21 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$151
  • TG Therapeutics, Inc.$125
  • AbbVie$98
  • Bristol Myers Squibb$68
  • UCB, Inc.$24
  • Neurocrine Biosciences, Inc.$19
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$518100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$518 in reported general payments places this provider in the 65th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$1,891
Medicare patients
16
Services billed
21

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$86,619
CopaxoneGlatiramer Acetate13$74,300
Teriflunomide36$61,156
Nurtec OdtRimegepant Sulfate34$36,289
RexultiBrexpiprazole16$33,390
OxycontinOxycodone Hcl67$31,941
Ajovy AutoinjectorFremanezumab-Vfrm20$15,549
Aimovig AutoinjectorErenumab-Aooe19$15,160
Emgality PenGalcanezumab-Gnlm12$8,948
Xtampza ErOxycodone Myristate16$8,320
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen532$7,577
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl49$6,679
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen329$6,153
Gabapentin503$6,041
Naloxone Hcl71$4,808

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$19$86,61912 claims
PfizerNurtec Odt$151$36,28934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Dearborn Heights

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →